LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Listă Acțiuni・NeoGenomics Inc

NeoGenomics Inc

Închisă

11.28 11.24

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

10.05

Maxim

11.57

Indicatori cheie
By Trading Economics
Venit	-7.2M -17M
Vânzări	-3.5M 187M
EPS	0.01
Marjă de profit	-9.164
Angajați	2,500
EBITDA	-5.8M -567K

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+47.24% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	239M 1.4B
Deschiderea anterioară	0.04
Închiderea anterioară	11.28

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 iun. 2026, 18:24 UTC

Market Talk

New Bitcoin Support Level at $65k -- Market Talk

3 iun. 2026, 17:21 UTC

Market Talk

Long Liquidations in Bitcoin Mount -- Market Talk

3 iun. 2026, 14:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 iun. 2026, 14:52 UTC

Market Talk

Privacy Coins Gain Amid BTC Weakness -- Market Talk

3 iun. 2026, 07:05 UTC

Market Talk

Bitcoin Falls After Fresh Attacks Between U.S. and Iran -- Market Talk

2 iun. 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

2 iun. 2026, 16:26 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 iun. 2026, 16:25 UTC

Market Talk

Solana Plummets as Memecoin Appetite Fades -- Market Talk

2 iun. 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 iun. 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

2 iun. 2026, 16:08 UTC

Market Talk

Global Equities Roundup: Market Talk

2 iun. 2026, 16:08 UTC

Market Talk

Bitcoin Out of Top 10 Assets as Downturn Deepens -- Market Talk

2 iun. 2026, 14:12 UTC

Market Talk

Fear in Control of Crypto Market -- Market Talk

2 iun. 2026, 14:10 UTC

Market Talk

Bitcoin Tumbles Below $70k on ETF Outflow -- Market Talk

2 iun. 2026, 11:25 UTC

Market Talk

Bitcoin Stays Weak on Geopolitical Uncertainty, Strategy's Sale of Cryptocurrency -- Market Talk

2 iun. 2026, 07:17 UTC

Market Talk

Bitcoin Extends Losses on Strategy Sale, Middle East Conflict -- Market Talk

1 iun. 2026, 16:54 UTC

Market Talk

Correction to Hyperliquid Market Talk

1 iun. 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 iun. 2026, 15:53 UTC

Market Talk

Hyperliquid Hits Record as ETFs Inflows Continue -- Market Talk

1 iun. 2026, 15:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 iun. 2026, 15:17 UTC

Market Talk

Late May Woes Look to Extend Into June for Crypto -- Market Talk

1 iun. 2026, 14:47 UTC

Market Talk

Money in Bitcoin ETFs Keep Flowing Out -- Market Talk

1 iun. 2026, 14:47 UTC

Market Talk

Global Equities Roundup: Market Talk

1 iun. 2026, 14:42 UTC

Achiziții, Fuziuni, Preluări

Strategy Sells Bitcoin for First Time Since 2022. The Stock Is Sliding. -- Barrons.com

1 iun. 2026, 13:58 UTC

Market Talk

Bitcoin Hits 7-Week Low After Report of Iran Halting Talks -- Market Talk

1 iun. 2026, 13:27 UTC

Market Talk

News of Strategy Sale of BTC Pressures Crypto -- Market Talk

1 iun. 2026, 11:42 UTC

Market Talk

Bitcoin Falls Amid Fears Over U.S.-Iran Conflict -- Market Talk

1 iun. 2026, 07:07 UTC

Market Talk

Bitcoin Falls as U.S.-Iran Conflict Dents Risk Appetite -- Market Talk

29 mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29 mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

47.24% sus

Prognoză pe 12 luni

Medie 14.93 USD 47.24%

Maxim 25 USD

Minim 11 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 10 analiști care au acordat evaluări ale acțiunilor NeoGenomics Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.